甘氨双唑钠对中晚期鼻咽癌放射治疗增敏临床评价.docVIP

甘氨双唑钠对中晚期鼻咽癌放射治疗增敏临床评价.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
甘氨双唑钠对中晚期鼻咽癌放射治疗增敏临床评价

甘氨双唑钠对中晚期鼻咽癌放射治疗增敏临床评价   [摘要] 目的 探讨甘氨双唑钠(CMNa)对中晚期鼻咽癌放射治疗增敏的临床疗效及安全性。方法 108例中晚期鼻咽癌患者随机分为实验组和对照组,实验组在常规放疗的基础上于放疗前1h静脉滴注CMNa 800mg/m2,每周3次,至放疗结束,对照组行常规放疗。观察两组患者的疗效及不良反应的发生情况。结果 两组患者在原发灶的完全缓解及总有效率,以及颈部淋巴结转移灶完全缓解率方面的比较,具有显著差异(P<0.05),在颈部淋巴结转移灶的总有效率方面,无显著差异(P>0.05)。两组患者在各种副作用的比较方面,无显著差异(P>0.05)。结论 甘氨双唑钠能够增加中晚鼻咽癌放疗敏感性,对不良反应无影响,具有良好的临床效果。   [关键词] 甘氨双唑钠;鼻咽癌;放射;疗效   [中图分类号] R739.6 [文献标识码] B [文章编号] 1673-9701(2011)34-65-02      Clinical Evaluation of Curative Effect to Sensitization of CMNa in Radiotherapy for Middle-late Nasopharyngeal Carcinoma   HU Guangwei   Department of Ear-nose-throat, Zhoushan Hospital Headquarters in Zhejiang Province, Zhoushan 316004,China      [Abstract] Objective To explore the clinical effectiveness and safety of CMNa on sensitizing in radiotherapy for middle-late nasopharyngeal carcinoma. Methods All 108 cases of patients with middle-late nasopharyngeal carcinoma were randomly divided into the experimental group and the control group. Patients in experimental group i.v.gtt CMNa with dose of 800mg/m2 at 1 hour before radiotherapy on the base of conventional radiotheraphy,3 times in every week. CMNa was used till the end of radiotherapy. In the control group,the patients taken conventional radiotheraphy,and curative effect and adverse reaction were contrasted between experimental group and the control group. Results Complete remission rate and total effective rate of primary lesion,complete remission rate of cervical lymph node metastases had significant difference between experimental group and the control group(P<0.05). Total effective rate of cervical lymph node metastases was identical between experimental group and the control group(P>0.05). Incidence rate of adverse reaction was identical l between experimental group and the control group(P>0.05). Conclusion CMNa could increase sensitivity of radiotherapy in middle-late nasopharyngeal carcinoma,and has no effect on adverse reaction. It has a good clinical effect.   [Key words] CMNa

文档评论(0)

317960162 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档